文献速递神经核医学

PRKN突变携带者血清素能功能丧失:[11C]DASB PET研究

Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-01-29

PURPOSE: We investigated serotonergic and dopaminergic terminal integrity role in PRKN-associated Parkinsonism (PRKN-PD) using [¹¹C]DASB Positron Emission Tomography (PET) and [¹²³I]FP-CIT Single Photon Emission Computerised Tomography (SPECT).…

要点

  • PRKN-PD患者多个皮层和皮层下ROI较健康对照存在20.8%至45.2%的[11C]DASB BPND丢失。
  • 校正年龄和病程后PRKN-PD与iPD的[11C]DASB BPND无差异。
  • 中缝、脑干、腹侧纹状体和杏仁核[11C]DASB BPND较高与NMSS评分较高相关。

核心结论

  • PRKN-PD以广泛的血清素能功能障碍为特征,该障碍独立于多巴胺能退变,并与抑郁等关键非运动症状相关。

主要发现

  • PRKN-PD患者多个皮层和皮层下ROI较健康对照存在20.8%至45.2%的[11C]DASB BPND丢失(p≤0.01)。
  • 校正年龄和病程后,PRKN-PD与iPD之间[11C]DASB BPND无差异。
  • PRKN-PD中,中缝、脑干、腹侧纹状体和杏仁核[11C]DASB BPND较高与Non-Motor Symptoms Scale评分较高相关(p<0.05)。
  • PRKN-PD中,尾状核和壳核[11C]DASB BPND较高与Beck Depression Inventory II评分较高相关(p<0.05)。
  • 尾状核和壳核中[11C]DASB BPND与[123I]FP-CIT SBR之间未检测到相关性。

临床怎么用

  • 对PRKN-PD患者应关注广泛血清素能功能障碍,尤其抑郁等非运动症状的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated serotonergic and dopaminergic terminal integrity role in PRKN-associated Parkinsonism (PRKN-PD) using [¹¹C]DASB Positron Emission Tomography (PET) and [¹²³I]FP-CIT Single Photon Emission Computerised Tomography (SPECT). METHODS: Fourteen PRKN-PD patients (mean age 49.70 ± 10.83, disease duration 10.95 ± 7.59 years, H&Y 2.0 ± 0.68), and twelve iPD patients (mean age 65.40 ± 7.48 years, disease duration 5.05 ± 4.50 years, H&Y 2.0 ± 0.93) underwent clinical assessments, 3-Tesla MRI, [11C]DASB PET-CT, and [123I]FP-CIT SPECT, and compared with previously acquired healthy control (HCs) data. [11C]DASB distribution volume ratio (DVR) parametric images were generated and DVR-1 values, equivalent to BPND, sampled from a priori selected regions-of-interest (ROIs) with the posterior cerebellum as reference. [123I]FP-CIT images underwent reconstruction and normalization to standard space, and striatal Specific Binding Ratio (SBR) calculated from the eight hottest consecutive slices. RESULTS: PRKN-PD patients showed 20.8% to 45.2% [11C]DASB BPND loss across several cortical and subcortical ROIs compared to HCs (p ≤ 0.01). After adjusting for age and disease duration, no differences in [11C]DASB BPND were observed between PRKN-PD and iPD. In PRKN-PD, higher [11C]DASB BPND in the raphe, brainstem, ventral striatum, and amygdala, correlated with higher scores on the Non-Motor Symptoms Scale (p < 0.05). Higher [11C]DASB BPND in the caudate and putamen correlated with higher scores on the Beck Depression Inventory II scale (p < 0.05). No correlation was detected between [11C]DASB BPND and [123I]FP-CIT SBR in the caudate and putamen. CONCLUSIONS: PRKN-PD is characterized by widespread serotonergic dysfunction, which is independent of dopaminergic degeneration and linked to key non-motor symptoms, particularly depression. These findings provide novel insights into the pathophysiology of PRKN-PD.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. de Natale ER, Wilson H, Verghese JP, et al. Loss of serotonergic function in carriers of PRKN mutations: a [11C]DASB PET study. Eur J Nucl Med Mol Imaging. 2026. PMID: 41606302. doi:10.1007/s00259-025-07693-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。